Up to the day about Atosiban name of the Medicinal product Tractocile 6.75 mg / 0.9 ml solution for injection

Authors

  • Yudith Guerrero Servicio de Perinatología. Sanatorio Allende. (Sede Nueva Córdoba). Còrdoba

DOI:

https://doi.org/10.59843/2618-3692.v17.n29.21715

Keywords:

Atosiban, premature birth, nursing, safe administration of medications

Abstract

Summary: this paper deals with the update of the use of atosiban for the treatment of the threat of preterm birth, using the protocol of administration of Tractocile in the delivery service vs general hospital for its application, for the purpose of systematizing nursing care In the use of this medicine.

Downloads

Download data is not yet available.

Author Biography

Yudith Guerrero, Servicio de Perinatología. Sanatorio Allende. (Sede Nueva Córdoba). Còrdoba

Lic en enfermería

References

- European Medicines Agency 2.009. Tractocile atosiban EPAR summary for the public. Acceso junio 2016, disponible en: http://www.ema.europa. eu/docs/en_GB/document_library/EPAR_-_ Summar y _ for _ the _ public/human/000253/ WC500040489.pdf

- Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) Alerta Farmacéutica R 57/2013 en: www.aemps.gob.es/medicamentosUsoHumano/ portada/home.htm

- Dirección Nacional de Maternidad e Infancia(2015) Recomendaciones para la prevención, diagnóstico y tratamiento de amenaza de parto pretérmino, atención del parto pretérmino espontáneo y rotura prematura de membranas (2015) Disponible en: http://www.msal.gob.ar/images/stories/bes/graficos/0000000710cnt-guia-parto-pretermino.pdf

Downloads

Published

2018-10-23

How to Cite

Guerrero, Y. (2018). Up to the day about Atosiban name of the Medicinal product Tractocile 6.75 mg / 0.9 ml solution for injection. Notas De Enfermería, 17(29). https://doi.org/10.59843/2618-3692.v17.n29.21715

Issue

Vol. 17 No. 29 (2017): Junio

Section

Artículos Originales

License

Copyright (c) 2018 Sanatorio Allende

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Those authors who have published with this journal, accept the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.